Literature DB >> 16897028

[Surgical management of spondylodiscitis. An analysis of 78 cases].

T M Frangen1, T Kälicke, M Gottwald, S Andereya, H-J Andress, O J Russe, E J Müller, G Muhr, C Schinkel.   

Abstract

Spondylodiscitis is a rare bacterial infection of the spine with an inflammatory, destructive course. To obtain further information on the therapeutic management and clinical course of spondylodiscitis, we retrospectively investigated 78 patients after surgical intervention. Mean age was 64 years (+/-4.6 years; range 21-80 years), the mean length of stay 49 days (+/-8.2 days; 3-121 days) including 24 days (+/-4.7 days; 0-112 days) in ICU. In hospital mortality was 9%. The cervical spine was affected in 10%, the thoracic spine in 35% and the lumbar/sacral spine in 55% of patients. Abscess formation occurred in 65% and destruction of the vertebral body in 74%. A total of 75% of patients presented with neurological deficits which could be improved by surgical intervention in 82% of cases. 24 patients were treated by ventral debridement and stabilization alone, 20 patients with a combined dorsoventral method. Most patients (n=34) were stabilized via dorsal bridging instrumentation without ventral debridement of the focus. Of this group, 23 patients were initially scheduled for secondary ventral debridement but complete healing was achieved prior to this, so further surgical therapy was unnecessary. Successful cure was obtained in 92% of cases. Based on our findings, we favor a split surgical approach: initially with dorsal internal fixation only. Abscesses can be drained percutaneously. Ventral debridement and stabilization is only recommended if insufficient stability can be obtained by dorsal fixation alone, as shown by the persistence of infection or pain.

Entities:  

Mesh:

Year:  2006        PMID: 16897028     DOI: 10.1007/s00113-006-1084-7

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  25 in total

1.  [Spondylodiscitis with presacral abscesses caused by fistulization in Crohn's disease of the small intestine].

Authors:  M Zajac; K Engelhard; R Schuhmann
Journal:  Rontgenpraxis       Date:  2000

2.  [MRI in spondylitis and spondylodiscitis].

Authors:  C H Flamme; D Lazoviae; F Gossé; O Rühmann
Journal:  Orthopade       Date:  2001-08       Impact factor: 1.087

3.  Primary stable anterior instrumentation or dorsoventral spondylodesis in spondylodiscitis? Results of a comparative study.

Authors:  P Eysel; C Hopf; I Vogel; J D Rompe
Journal:  Eur Spine J       Date:  1997       Impact factor: 3.134

4.  Primary reconstruction for spinal infections.

Authors:  D D Dietze; R G Fessler; R P Jacob
Journal:  J Neurosurg       Date:  1997-06       Impact factor: 5.115

5.  [Development and validation of the Visual Analogue Scale (VAS) Spine Score].

Authors:  C Knop; M Oeser; L Bastian; U Lange; M Zdichavsky; M Blauth
Journal:  Unfallchirurg       Date:  2001-06       Impact factor: 1.000

6.  Anterior fusion of the spine for infective lesions in adults.

Authors:  H B Kemp; J W Jackson; J D Jeremiah; J Cook
Journal:  J Bone Joint Surg Br       Date:  1973-11

7.  [Unspecific spondylodiscitis following anastomotic leakage after rectal resection].

Authors:  M Gottwald; H-J Andress; C Schinkel
Journal:  Zentralbl Chir       Date:  2003-04       Impact factor: 0.942

Review 8.  Infectious disease of the spine. Diagnostic and treatment considerations.

Authors:  R J Wisneski
Journal:  Orthop Clin North Am       Date:  1991-07       Impact factor: 2.472

9.  Surgical treatment of spondylodiscitis.

Authors:  Christian Schinkel; Matthias Gottwald; Hans-Joachim Andress
Journal:  Surg Infect (Larchmt)       Date:  2003       Impact factor: 2.150

Review 10.  Wound infections in reconstructive spine surgery.

Authors:  S M Theiss; J E Lonstein; R B Winter
Journal:  Orthop Clin North Am       Date:  1996-01       Impact factor: 2.472

View more
  29 in total

Review 1.  Treatment of spondylodiscitis.

Authors:  Kourosh Zarghooni; Marc Röllinghoff; Rolf Sobottke; Peer Eysel
Journal:  Int Orthop       Date:  2011-12-06       Impact factor: 3.075

2.  [Systemic and local antibiotic therapy of conservative and operative treatment of spondylodiscitis].

Authors:  C Fleege; T A Wichelhaus; M Rauschmann
Journal:  Orthopade       Date:  2012-09       Impact factor: 1.087

Review 3.  [Infections of the spine : Therapeutic strategies].

Authors:  S Weckbach; B Lutz; J V Wölfle-Roos; H Reichel
Journal:  Chirurg       Date:  2016-10       Impact factor: 0.955

4.  Spondylodiscitis severity code: scoring system for the classification and treatment of non-specific spondylodiscitis.

Authors:  L Homagk; N Homagk; J R Klauss; K Roehl; G O Hofmann; D Marmelstein
Journal:  Eur Spine J       Date:  2015-04-21       Impact factor: 3.134

5.  Complex 360°-reconstruction and stabilization of the cervical spine due to osteomyelitis.

Authors:  Martin Strowitzki; Jan Vastmans; Matthias Vogel; Hans Jaksche
Journal:  Eur Spine J       Date:  2010-12-01       Impact factor: 3.134

6.  [Pyogenic spondylodiscitis of the thoracic and lumbar spine : a new classification and guide for surgical decision-making].

Authors:  M Akbar; B Lehner; S Doustdar; C H Fürstenberg; S Hemmer; T Bruckner; C Carstens; B Wiedenhöfer
Journal:  Orthopade       Date:  2011-07       Impact factor: 1.087

7.  Current diagnosis and treatment of spondylodiscitis.

Authors:  Rolf Sobottke; Harald Seifert; Gerd Fätkenheuer; Matthias Schmidt; Axel Gossmann; Peer Eysel
Journal:  Dtsch Arztebl Int       Date:  2008-03-07       Impact factor: 5.594

8.  [Operative therapy of bacterial spondylodiscitis: a retrospective study].

Authors:  C Ewald; J Gartemann; S A Kuhn; J Walter; R Kalff
Journal:  Orthopade       Date:  2009-03       Impact factor: 1.087

Review 9.  Acute Lumbar Back Pain.

Authors:  Hans-Raimund Casser; Susann Seddigh; Michael Rauschmann
Journal:  Dtsch Arztebl Int       Date:  2016-04-01       Impact factor: 5.594

10.  Posterior instrumentation, anterior column reconstruction with single posterior approach for treatment of pyogenic osteomyelitis of thoracic and lumbar spine.

Authors:  M Gorensek; R Kosak; L Travnik; R Vengust
Journal:  Eur Spine J       Date:  2012-08-25       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.